Loncar Cancer Immunotherapy ETF CNCR NASDAQ

NASDAQ Global Market • Financial Services • Asset Management • US • USD

SharesGrow Intrinsic Value

N/A

Negative cash flow

股票统计 — CNCR

Loncar Cancer Immunotherapy ETF (CNCR) 的市值为 $7.04M 交易价格为 $9.02. 52周价格区间为 7.881-16.27.

该股票拥有 Beta值为 0.96, 运营于 Financial Services 板块.

交易数据

当前价格$9.02

52周区间7.881-16.27

成交量3.08K

30日平均成交量2.15K

市值$7.04M

Beta（1年）0.96

公司信息

IPO日期2015-10-14

国家US

交易所NASDAQ Global Market

货币USD

ISINUS26922A8264

CUSIP26922A826

损益表（最近年度）

资产负债表（最近年度）

估值比率

其他人也在看

SBIO

ALPS Medical Breakthroughs ETF

$56.67

+0.91%

BBC

Virtus LifeSci Biotech Clinical Trials ETF

$45.98

+1.29%

BBP

Virtus LifeSci Biotech Products ETF

$87.08

-0.06%

BTEC

Principal Healthcare Innovators ETF

$39.49

+1.02%

CHNA

Loncar China BioPharma ETF

$13.53

-0.07%

VITSX

Vanguard Total Stock Market Index Fund Institutional Shares

$166.82

+1.15%

VTSAX

Vanguard Total Stock Market Index Fund Admiral Shares

$166.79

+1.15%

VSMPX

Vanguard Total Stock Market Index Fund Institutional Plus Shares

$312.93

+1.15%

Loncar Cancer Immunotherapy ETF CNCR NASDAQ

股票统计 — CNCR

其他人也在看

获取低估股票提醒